Guilin Sanjin Pharmaceutical Co.,Ltd.’s Net Profit Dropped 4.1% in 2022

Guilin Sanjin Pharmaceutical Co.,Ltd. (桂林三金药业股份有限公司) (002275.SZ) reported a net profit of 329.5 million yuan in 2022, down 4.1% year-on-year.

Meanwhile, the company posted 2 billion yuan in revenue, up 12.5% year-on-year.

At the end of the reporting period, it had 4 billion yuan in total assets and 1.2 billion yuan in total liabilities, with a liability-to-asset ratio of 29%.